Ankur Karmokar

1.4k total citations
15 papers, 640 citations indexed

About

Ankur Karmokar is a scholar working on Oncology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Ankur Karmokar has authored 15 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 3 papers in Molecular Medicine. Recurrent topics in Ankur Karmokar's work include Cancer Cells and Metastasis (4 papers), Curcumin's Biomedical Applications (3 papers) and PARP inhibition in cancer therapy (3 papers). Ankur Karmokar is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Curcumin's Biomedical Applications (3 papers) and PARP inhibition in cancer therapy (3 papers). Ankur Karmokar collaborates with scholars based in United Kingdom, Iraq and Singapore. Ankur Karmokar's co-authors include Karen Brown, William P. Steward, Andreas J. Gescher, David P. Berry, Lynne Howells, Catherine Andreadi, Anne Thomas, Victoria Brown, Robert G. Britton and Stewart Sale and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Ankur Karmokar

15 papers receiving 627 citations

Peers

Ankur Karmokar

ONCOL

Edwina N. Scott United Kingdom

Young-Sam Keum United States

Noor Hasima Malaysia

Lalitha Ramachandran Singapore

Rosanna Mattera Italy

Myung Gu Jung South Korea

Guoguo Jin China

Christos Kazazis Greece

Khushbukhat Khan Pakistan

Edwina N. Scott United Kingdom

Ankur Karmokar

430 ×1.4

107 ×0.7

281 ×2.1

ONCOL

270 ×2.6

66 ×0.9

Citations per year, relative to Ankur Karmokar Ankur Karmokar (= 1×) peers Edwina N. Scott

Countries citing papers authored by Ankur Karmokar

Since Specialization

Citations

This map shows the geographic impact of Ankur Karmokar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankur Karmokar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankur Karmokar more than expected).

Fields of papers citing papers by Ankur Karmokar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankur Karmokar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankur Karmokar. The network helps show where Ankur Karmokar may publish in the future.

Co-authorship network of co-authors of Ankur Karmokar

This figure shows the co-authorship network connecting the top 25 collaborators of Ankur Karmokar. A scholar is included among the top collaborators of Ankur Karmokar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankur Karmokar. Ankur Karmokar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Karmokar, Ankur, Adina Hughes, Zena Wilson, et al.. (2023). Relevance of ATM Status in Driving Sensitivity to DNA Damage Response Inhibitors in Patient-Derived Xenograft Models. Cancers. 15(16). 4195–4195. 4 indexed citations

Albertella, Mark R., Paul W.G. Wijnhoven, Annie Albert Demin, et al.. (2023). Abstract B058: Combination of the PARP1-selective inhibitor AZD5305 with the ATR inhibitor ceralasertib for the treatment of PARPi-resistant cancer. Molecular Cancer Therapeutics. 22(12_Supplement). B058–B058. 1 indexed citations

Khan, Sam, Gareth J. Miles, Kevin West, et al.. (2022). Ex vivo explant model of adenoma and colorectal cancer to explore mechanisms of action and patient response to cancer prevention therapies. Mutagenesis. 37(5-6). 227–237. 7 indexed citations

Wallez, Yann, Theresa A. Proia, Ankur Karmokar, et al.. (2022). Abstract 5298: Activity and tolerability of combinations of trastuzumab deruxtecan (T-DXd) with inhibitors of the DNA damage response in preclinical models. Cancer Research. 82(12_Supplement). 5298–5298. 1 indexed citations

Nakamura, Kyoko, Ankur Karmokar, Paul Farrington, et al.. (2021). Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control. Clinical Cancer Research. 27(15). 4353–4366. 43 indexed citations

Ramos‐Montoya, Antonio, Mercedes Vázquez–Chantada, Paul W.G. Wijnhoven, et al.. (2019). Abstract 3506: AZD7648, a potent and selective inhibitor of DNA-PK, potentiates activity of the PARP inhibitor olaparib resulting in sustained anti-tumour activity in xenograft and PDX models. 1 indexed citations

Alexandrou, Constantia, Jennifer A. Higgins, William Boyle, et al.. (2018). Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes. Scientific Reports. 8(1). 12096–12096. 67 indexed citations

Núñez‐Sánchez, María Ángeles, Ankur Karmokar, Antonio González‐Sarrías, et al.. (2016). In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: A new potentiality for ellagitannin metabolites against cancer. Food and Chemical Toxicology. 92. 8–16. 53 indexed citations

Khan, Sameena, Ankur Karmokar, Lynne Howells, et al.. (2016). Targeting cancer stem‐like cells using dietary‐derived agents – Where are we now?. Molecular Nutrition & Food Research. 60(6). 1295–1309. 15 indexed citations

10.

James, Mark I., Chinenye Iwuji, Ankur Karmokar, et al.. (2015). Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. Cancer Letters. 364(2). 135–141. 145 indexed citations

11.

James, Mark I., Lynne Howells, Ankur Karmokar, et al.. (2015). Characterization and Propagation of Tumor Initiating Cells Derived from Colorectal Liver Metastases: Trials, Tribulations and a Cautionary Note. PLoS ONE. 10(2). e0117776–e0117776. 6 indexed citations

12.

Andreadi, Catherine, Robert G. Britton, Emma Horner‐Glister, et al.. (2013). Sulfate Metabolites Provide an Intracellular Pool for Resveratrol Generation and Induce Autophagy with Senescence. Science Translational Medicine. 5(205). 205ra133–205ra133. 166 indexed citations

13.

Karmokar, Ankur, et al.. (2013). The role of cancer stem cells in the anti‐carcinogenicity of curcumin. Molecular Nutrition & Food Research. 57(9). 1630–1637. 36 indexed citations

14.

Karmokar, Ankur, Timothy H. Marczylo, Hong Cai, et al.. (2012). Dietary intake of rosmarinic acid by Apc^Min mice, a model of colorectal carcinogenesis: levels of parent agent in the target tissue and effect on adenoma development. Molecular Nutrition & Food Research. 56(5). 775–783. 16 indexed citations

15.

Karmokar, Ankur, et al.. (2011). Curcumin: The potential for efficacy in gastrointestinal diseases. Best Practice & Research Clinical Gastroenterology. 25(4-5). 519–534. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact